{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:30:22Z","timestamp":1777923022601,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:p>\n                    An essential part of the Israeli intervention program aimed to contain the spread of carbapenemase-producing Enterobacterales (CPE) has been the establishment of national surveillance system, where the institutional rates are determined by both clinical and surveillance cultures. The objectives of the study were to analyze the effect of changes in surveillance culture media on the rates and microbiological characteristics of CPE in a multicenter study. The rates were compared during 2 years in and between four centers. Two centers (Tel-Aviv and Beilinson) had changed their surveillance media to CHROMagar\u2122 mSuperCARBA\u2122 after 1 year, and two centers (Rambam and Hillel-Yaffe) had continued to use CHROMagar KPC. There was an increase in the rates of surveillance CPE in Tel-Aviv and Beilinson following the change in media, whereas the rates remained the same or declined in Rambam and Hillel-Yaffe, respectively. The rates of clinical CPE remained unchanged in Rambam and Hillel-Yaffe, declined in Tel-Aviv, and increased in Beilinson but to a lesser extent compared with the increase in surveillance CPE. The relative composition of the CPE mechanisms and species changed in Tel-Aviv, with an increase in non-\n                    <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                    species and in carbapenemase other than KPC. Our study shows that changes in surveillance media may contribute to significant changes in the rate of surveillance CPE that may be irrespective of actual epidemiological changes. Therefore, determination of institutional burden of CPE and the assessment of intervention results should be based primarily on the rate of clinical CPE rather than surveillance culture reports.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2019.0478","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T03:13:50Z","timestamp":1588907630000},"page":"1350-1356","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Institutional Burden of Carbapenemase-Producing Enterobacterales: The Effect of Changes in Surveillance Culture Methodology"],"prefix":"10.1177","volume":"26","author":[{"given":"Amit","family":"Yavor","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Ben-Zvi","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarit","family":"Freeman","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Hillel-Yaffe Medical Center, Hadera, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Geffen","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Rambam Medical Center, Haifa, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos","family":"Adler","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel."},{"name":"Microbiology Laboratory, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir025"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx135"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2015.08.007"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku333"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01686-12"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00280-11"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.02.004"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02566-10"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2017.211"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr382"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00568-07"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit795"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/003335490912400320"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2004.00256.x"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.9.1900123"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix113"},{"key":"e_1_3_4_19_2","first-page":"101","article-title":"Evaluation of CHROMagarTMmSuperCARBATM for the detection of carbapenemase-producing gram-negative organisms","volume":"70","author":"Creighton J.","year":"2016","unstructured":"Creighton J., , and Wang H.. 2016. Evaluation of CHROMagarTMmSuperCARBATM for the detection of carbapenemase-producing gram-negative organisms. N. Z. J. Med. Lab. Sci. 70:101\u2013105.","journal-title":"N. Z. J. Med. Lab. Sci"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12634"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.05.032"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01613-12"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2018.08.005"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.11.014"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2019.0478","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2019.0478","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2019.0478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:37:14Z","timestamp":1777667834000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/mdr.2019.0478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"alternative-id":["10.1089\/mdr.2019.0478"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2019.0478","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]}}}